• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Compass Therapeutics, Inc. - Common Stock (NQ:CMPX)

    2.355 -0.005 (-0.21%)
    Streaming Delayed Price Updated: 3:00 PM EDT, Aug 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 983,844
    Open 2.390
    Bid (Size) 2.350 (8,200)
    Ask (Size) 2.360 (11,000)
    Prev. Close 2.360
    Today's Range 2.330 - 2.450
    52wk Range 1.610 - 6.880
    Shares Outstanding 127,486,326
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win ↗
    Compass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody,... 
    Via MarketBeat

    Performance

    YTD
    -54.4%
    -54.4%
    1 Month
    +12.1%
    +12.1%
    3 Month
    +22.0%
    +22.0%
    6 Month
    -63.1%
    -63.1%
    1 Year
    -15.3%
    -15.3%

    More News

    Read More
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
    From Pomerantz LLP
    Via GlobeNewswire
    On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    Monday's session: most active stocks ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    Top movers in Friday's after hours session ↗
    Via Chartmill
    News headline image
    ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch ↗
    Via The Motley Fool
    News headline image
    Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era
    From USA News Group
    Via GlobeNewswire
    News headline image
    Compass Therapeutics Inc (NASDAQ:CMPX) Reports Wider Q2 2025 Loss, Shares Show Mixed Reaction Amid Clinical Progress ↗
    Via Chartmill
    News headline image
    Compass Therapeutics Posts Wider Q2 Loss ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Earnings Scheduled For August 11, 2025 ↗
    Via Benzinga
    News headline image
    Top movers in Wednesday's session ↗
    Via Chartmill
    News headline image
    Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer ↗
    Via Benzinga
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
    Via Benzinga
    News headline image
    Top 3 High-Momentum Companies Analysts Are Still Bullish On
    Via MarketBeat
    News headline image
    CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024 ↗
    Via InvestorPlace

    Frequently Asked Questions

    Is Compass Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Compass Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Compass Therapeutics, Inc. - Common Stock trade on?
    Compass Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Compass Therapeutics, Inc. - Common Stock?
    The ticker symbol for Compass Therapeutics, Inc. - Common Stock is CMPX on the Nasdaq Stock Market
    What is the current price of Compass Therapeutics, Inc. - Common Stock?
    The current price of Compass Therapeutics, Inc. - Common Stock is 2.355
    When was Compass Therapeutics, Inc. - Common Stock last traded?
    The last trade of Compass Therapeutics, Inc. - Common Stock was at 08/21/26 03:00 PM ET
    What is the market capitalization of Compass Therapeutics, Inc. - Common Stock?
    The market capitalization of Compass Therapeutics, Inc. - Common Stock is 300.23M
    How many shares of Compass Therapeutics, Inc. - Common Stock are outstanding?
    Compass Therapeutics, Inc. - Common Stock has 300M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.